SEC Comment Letter 0000000000-23-001061 to NaturalShrimp Inc (SHMP) (CIK 0001465470)
NaturalShrimp Inc (SHMP) (CIK 0001465470)
Date: Feb. 1, 2023 · CIK: 0001465470 · Accession: 0000000000-23-001061
AI Filing Summary & Sentiment
File numbers found in text: 000-54030
Show Raw Text
United States securities and exchange commission logo
February 1, 2023
William Delgado
Chief Financial Officer
NaturalShrimp Inc.
5501 LBJ Freeway, Suite 450
Dallas, TX 75240
Re:NaturalShrimp Inc.
Form 10-K for the Fiscal Year Ended March 31, 2022
Filed June 29, 2022
Form 10-Q for the Quarterly Period Ended September 30, 2022
Filed November 14, 2022
File No. 000-54030
Dear William Delgado:
We have limited our review of your filing to the financial statements and related
disclosures and have the following comments. In some of our comments, we may ask you to
provide us with information so we may better understand your disclosure.
Please respond to these comments within ten business days by providing the requested
information or advise us as soon as possible when you will respond. If you do not believe our
comments apply to your facts and circumstances, please tell us why in your response.
After reviewing your response to these comments, we may have additional comments.
Form 10-K for the Fiscal Year Ended March 31, 2022
Expenses, page 34
1.Please expand your disclosures to present and discuss Other Income (Expense) for the
year ended March 31, 2022 versus March 31, 2021.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Revenue, page 34
2.Please provide additional insight, discussion and analysis related to your initial sample
orders to customers. Refer to Item 303 of Regulation S-K.
FirstName LastNameWilliam Delgado
Comapany NameNaturalShrimp Inc.
February 1, 2023 Page 2
FirstName LastName
William Delgado
NaturalShrimp Inc.
February 1, 2023
Page 2
Consolidated Financial Statements
Consolidated Statements of Cash Flows, page F-6
3.We note cash paid for License Agreement was $2,350,000. Please reconcile for us this
amount with the disclosure in Note 6, page F-13.
Note 2 - Summary of Significant Accounting Policies, page F-8
4.Please disclose your revenue recognition accounting policy, and provide any applicable
disclosures required by ASC 606. Separately address your accounting for initial sample
orders.
Form 10-Q for the Quarterly Period Ended September 30, 2022
Note 7 - Stockholders' Equity
Common Stock Issued in Relation to Business Agreement, page 16
5.Please tell us and disclose how you accounted for the 250,000 common shares issued in
relation to a trial distribution agreement. As part of your response, clarify whether you
applied the guidance in ASC 606-10-32-25 through 32-27. In addition, explain to us in
further detail the following disclosure: The shares will be paid by the Company
withholding sufficient profits from the sale by the other party of the live shrimp.
In closing, we remind you that the company and its management are responsible for the
accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or
absence of action by the staff.
You may contact Michael Fay at 202-551-3812 or Jeanne Baker, Senior Accountant, at
202-551-3691 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services